An interfering component in cardiac troponin I immunoassays—Its nature and inhibiting effect on the binding of antibodies against different epitopes
- 4 March 2004
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 37 (6) , 472-480
- https://doi.org/10.1016/j.clinbiochem.2004.01.007
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Evaluation of the AccuTnI Cardiac Troponin I Assay for Risk Assessment in Acute Coronary SyndromesClinical Chemistry, 2003
- Negative Interference in Cardiac Troponin I Immunoassays from a Frequently Occurring Serum and Plasma ComponentClinical Chemistry, 2003
- Clinical and Analytical Performance of the Liaison Cardiac Troponin I Assay in Unstable Coronary Artery Disease, and the Impact of Age on the Definition of Reference Limits. A FRISC-II SubstudyClinical Chemistry, 2003
- Strategy for Analysis of Cardiac Troponins in Biological Samples with a Combination of Affinity Chromatography and Mass SpectrometryClinical Chemistry, 2003
- Troponin: an important prognostic marker and risk-stratification tool in non–ST-segment elevation acute coronary syndromesJournal of the American College of Cardiology, 2003
- Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy)The American Journal of Cardiology, 2002
- Quality Specifications for Cardiac Troponin Assayscclm, 2001
- Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial InfarctionCirculation, 2000
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJournal of the American College of Cardiology, 2000
- Troponin and TropomyosinCirculation Research, 1998